Travel & Leisure
Andrew Fein Initiated (BCRX) at Strong Buy and Held Target at $21 on, Mar 10th, 2014
Andrew Fein of HC Wainwright & Co., Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy and Held Target at $21 on, Mar 10th, 2014.
Andrew has made no other calls on BCRX in the last 4 months.
There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Justin Kim of "Oppenheimer" Initiated at Hold on, Thursday, February 27th, 2014
This is the rating of the analyst that currently disagrees with Andrew
- Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell on, Tuesday, January 28th, 2014
Similar Travel and Leisure Articles
[ Fri, Jan 10th 2014
] - WOPRAI
[ Tue, Sep 17th 2013
] - WOPRAI
[ Mon, Jul 15th 2013
] - WOPRAI
[ Thu, Jul 11th 2013
] - WOPRAI
[ Mon, May 13th 2013
] - WOPRAI
[ Thu, Apr 18th 2013
] - WOPRAI
[ Tue, Feb 19th 2013
] - WOPRAI
[ Fri, Jan 25th 2013
] - WOPRAI
[ Wed, Oct 03rd 2012
] - WOPRAI